You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial

Citation Tools

Article menu

Download PDFPDF

XML
Interstitial lung disease
Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Maher TM, Stowasser S, Nishioka Y, et al
Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial
BMJ Open Respiratory Research 2018;5:e000325. doi: 10.1136/bmjresp-2018-000325